Pharmaceutical industry braces itself for government changes to drug pricing
The new Government has indicated that drug pricing will be subject to value-based pricing through NICE, which may delay drug launches.
BMJ 2010; 340:c2933
04/06/2010
No Comments »
No comments yet.
RSS feed for comments on this post. TrackBack URL
Leave a comment
You must be logged in to post a comment.